A Machine Learning Framework for Pathway-Driven Therapeutic Target Discovery in Metabolic Disorders

• URL: http://arxiv.org/abs/2509.18140v1
• Date: Sun, 14 Sep 2025 19:29:52 GMT
• Title: A Machine Learning Framework for Pathway-Driven Therapeutic Target Discovery in Metabolic Disorders
• Authors: Iram Wajahat, Amritpal Singh, Fazel Keshtkar, Syed Ahmad Chan Bukhari,
• Abstract summary: This study introduces a novel machine learning (ML) framework that integrates predictive modeling with gene-agnostic pathway mapping to identify high-risk individuals.<n>Using the Pima Indian dataset, logistic regression and t-tests were applied to identify key predictors of T2DM, yielding an overall model accuracy of 78.43%.
• Score: 1.41678086736482
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Metabolic disorders, particularly type 2 diabetes mellitus (T2DM), represent a significant global health burden, disproportionately impacting genetically predisposed populations such as the Pima Indians (a Native American tribe from south central Arizona). This study introduces a novel machine learning (ML) framework that integrates predictive modeling with gene-agnostic pathway mapping to identify high-risk individuals and uncover potential therapeutic targets. Using the Pima Indian dataset, logistic regression and t-tests were applied to identify key predictors of T2DM, yielding an overall model accuracy of 78.43%. To bridge predictive analytics with biological relevance, we developed a pathway mapping strategy that links identified predictors to critical signaling networks, including insulin signaling, AMPK, and PPAR pathways. This approach provides mechanistic insights without requiring direct molecular data. Building upon these connections, we propose therapeutic strategies such as dual GLP-1/GIP receptor agonists, AMPK activators, SIRT1 modulators, and phytochemical, further validated through pathway enrichment analyses. Overall, this framework advances precision medicine by offering interpretable and scalable solutions for early detection and targeted intervention in metabolic disorders. The key contributions of this work are: (1) development of an ML framework combining logistic regression and principal component analysis (PCA) for T2DM risk prediction; (2) introduction of a gene-agnostic pathway mapping approach to generate mechanistic insights; and (3) identification of novel therapeutic strategies tailored for high-risk populations.

Related papers

• Investigating the Impact of Histopathological Foundation Models on Regressive Prediction of Homologous Recombination Deficiency [52.50039435394964]
  We systematically evaluate foundation models for regression-based tasks.<n>We extract patch-level features from whole slide images (WSI) using five state-of-the-art foundation models.<n>Models are trained to predict continuous HRD scores based on these extracted features across breast, endometrial, and lung cancer cohorts.
  arXiv  Detail & Related papers  (2026-01-29T14:06:50Z)
• R-GenIMA: Integrating Neuroimaging and Genetics with Interpretable Multimodal AI for Alzheimer's Disease Progression [63.97617759805451]
  Early detection of Alzheimer's disease requires models capable of integrating macro-scale neuroanatomical alterations with micro-scale genetic susceptibility.<n>We introduce R-GenIMA, an interpretable multimodal large language model that couples a novel ROI-wise vision transformer with genetic prompting.<n>R-GenIMA achieves state-of-the-art performance in four-way classification across normal cognition, subjective memory concerns, mild cognitive impairment, and AD.
  arXiv  Detail & Related papers  (2025-12-22T02:54:10Z)
• Integrating Genomics into Multimodal EHR Foundation Models [56.31910745104141]
  This paper introduces an innovative EHR foundation model that integrates Polygenic Risk Scores (PRS) as a foundational data modality.<n>The framework aims to learn complex relationships between clinical data and genetic predispositions.<n>This approach is pivotal for unlocking new insights into disease prediction, proactive health management, risk stratification, and personalized treatment strategies.
  arXiv  Detail & Related papers  (2025-10-24T15:56:40Z)
• Sequence-based protein-protein interaction prediction and its applications in drug discovery [0.6827423171182154]
  We outline the state-of the-art for sequence-based PPI prediction methods and explore their impact on target identification and drug discovery.<n>We provide examples of PPI prediction in systems-level analyses, target identification, and design of therapeutic peptides and antibodies.
  arXiv  Detail & Related papers  (2025-07-26T05:37:55Z)
• PRING: Rethinking Protein-Protein Interaction Prediction from Pairs to Graphs [80.08310253195144]
  PRING is the first benchmark that evaluates protein-protein interaction prediction from a graph-level perspective.<n> PRING curates a high-quality, multi-species PPI network dataset comprising 21,484 proteins and 186,818 interactions.
  arXiv  Detail & Related papers  (2025-07-07T15:21:05Z)
• KEPLA: A Knowledge-Enhanced Deep Learning Framework for Accurate Protein-Ligand Binding Affinity Prediction [60.23701115249195]
  KEPLA is a novel deep learning framework that integrates prior knowledge from Gene Ontology and ligand properties to enhance prediction performance.<n> Experiments on two benchmark datasets demonstrate that KEPLA consistently outperforms state-of-the-art baselines.
  arXiv  Detail & Related papers  (2025-06-16T08:02:42Z)
• scGSDR: Harnessing Gene Semantics for Single-Cell Pharmacological Profiling [5.831554646284266]
  scGSDR is a model that integrates two computational pipelines grounded in the knowledge of cellular states and gene signaling pathways.<n> scGSDR enhances predictive performance by incorporating gene semantics and employs an interpretability module.<n>The model's application has extended from single-drug predictions to scenarios involving drug combinations.
  arXiv  Detail & Related papers  (2025-02-02T15:43:20Z)
• Multiscale Topology in Interactomic Network: From Transcriptome to Antiaddiction Drug Repurposing [0.3683202928838613]
  The escalating drug addiction crisis in the United States underscores the urgent need for innovative therapeutic strategies. This study embarked on an innovative and rigorous strategy to unearth potential drug repurposing candidates for opioid and cocaine addiction treatment.
  arXiv  Detail & Related papers  (2023-12-03T04:01:38Z)
• AI-Bind: Improving Binding Predictions for Novel Protein Targets and Ligands [9.135203550164833]
  We show that state-of-the-art models fail to generalize to novel structures. We introduce AI-Bind, a pipeline that combines network-based sampling strategies with unsupervised pre-training. We illustrate the value of AI-Bind by predicting drugs and natural compounds with binding affinity to SARS-CoV-2 viral proteins.
  arXiv  Detail & Related papers  (2021-12-25T01:52:58Z)
• Lung Cancer Lesion Detection in Histopathology Images Using Graph-Based Sparse PCA Network [93.22587316229954]
  We propose a graph-based sparse principal component analysis (GS-PCA) network, for automated detection of cancerous lesions on histological lung slides stained by hematoxylin and eosin (H&E) We evaluate the performance of the proposed algorithm on H&E slides obtained from an SVM K-rasG12D lung cancer mouse model using precision/recall rates, F-score, Tanimoto coefficient, and area under the curve (AUC) of the receiver operator characteristic (ROC)
  arXiv  Detail & Related papers  (2021-10-27T19:28:36Z)
• Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response [49.86828302591469]
  In this paper, we apply transfer learning to the prediction of anti-cancer drug response. We apply the classic transfer learning framework that trains a prediction model on the source dataset and refines it on the target dataset. The ensemble transfer learning pipeline is implemented using LightGBM and two deep neural network (DNN) models with different architectures.
  arXiv  Detail & Related papers  (2020-05-13T20:29:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.